AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD
Clinical trials for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD explained in plain language.
Never miss a new study
Get alerted when new AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD trials appear
Sign up with your email to follow new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets genetic kidney disease in first human trial
Disease control Recruiting nowThis early-stage study tests a new medicine called PYC-003 in healthy people and those with autosomal dominant polycystic kidney disease (ADPKD), a genetic condition that causes fluid-filled cysts to grow in the kidneys. The main goal is to check the drug's safety and how the bod…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD
Phase: PHASE1 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated May 26, 2026 05:13 UTC
-
Could a keto diet help slow kidney disease?
Disease control Recruiting nowThis study tests a 16-week nutritionist-led ketogenic diet program called Ren-Nu, combined with a medical food (KetoCitra), in 20 adults with autosomal dominant polycystic kidney disease (ADPKD). The goal is to see if the diet can improve kidney function, blood sugar, and inflamm…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD
Phase: NA • Sponsor: Richard Fatica • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
New pill aims to shrink kidney cysts in genetic disease
Disease control Recruiting nowThis study tests an experimental drug called VX-407 in 24 adults with autosomal dominant polycystic kidney disease (ADPKD) who have certain changes in the PKD1 gene. The goal is to see if the drug can slow or reduce kidney growth and check for side effects. Participants will take…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New hope for dialysis patients: Non-Surgical kidney shrinkage could clear path to transplant
Disease control Recruiting nowThis study looks at a non-surgical procedure called renal embolization to shrink enlarged kidneys in 30 dialysis patients with autosomal dominant polycystic kidney disease (ADPKD). The goal is to reduce kidney size enough to allow for a kidney transplant, which is often delayed w…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Can MRI and genetic tests catch kidney disease early in At-Risk youth?
Knowledge-focused Recruiting nowThis study looks at children and teens (ages 12-17) who have a parent with autosomal dominant polycystic kidney disease (ADPKD) to find out how many have high blood pressure. Researchers will use MRI scans and genetic tests to diagnose ADPKD early. The goal is to better understan…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD
Sponsor: King's College London • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC